| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 11/11/2004 | CA2523537A1 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice |
| 11/11/2004 | CA2519241A1 Compositions and methods for the diagnosis and treatment of tumor |
| 11/10/2004 | EP1475440A2 Growth differentiation factor-3 |
| 11/10/2004 | EP1474430A1 Bi-functionalised metallocenes use for marking biological molecules |
| 11/10/2004 | EP1474396A2 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 11/10/2004 | EP1474178A1 Benzothiazole derivatives for in vivo imaging of amyloid plaques |
| 11/10/2004 | EP1474177A2 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts |
| 11/10/2004 | EP1202671A4 Microparticles useful as ultrasonic contrast agents and for lymphatic system |
| 11/10/2004 | EP1011422B1 Imaging of light scattering tissues with fluorescent contrast agents |
| 11/10/2004 | EP0800831B9 Diagnostic marker |
| 11/10/2004 | CN1545425A Light-stabilized in vivo stain composition and method of manufacture |
| 11/09/2004 | US6815575 For identifying genes that prevent cell/tissue (neural, muscle, mesoderm, kidney) degradation/apoptosis using transgenic drosophila |
| 11/09/2004 | US6815574 Methods of simulating human prostate cancer progression |
| 11/09/2004 | US6815438 Heteroaryl-diazabicycloalkanes |
| 11/09/2004 | US6815186 Implantable glucose sensor |
| 11/04/2004 | WO2004094647A2 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 11/04/2004 | WO2004093922A1 Methods of producing carbon-13 labeled biomass |
| 11/04/2004 | WO2004093921A1 Mr-signal emitting coatings |
| 11/04/2004 | WO2004093907A2 Therapeutic agents for treating dermatitis, alopecia and itching and transgenic animals for evaluating such therapeutic agents |
| 11/04/2004 | WO2004034029A3 Screening systems and methods for identifying modulators of xenobiotic metabolism |
| 11/04/2004 | WO2003091696A3 Process for identifying and treating specified cell types |
| 11/04/2004 | WO2003086324A3 Preparation and use of a stable formulation of allosteric effector compounds |
| 11/04/2004 | US20040220480 Method and device for determining a characteristic value for the perfusion of modified tissue regions in organs of living beings |
| 11/04/2004 | US20040220147 Antiarrhythmia agents; liver disorders; skin disorders |
| 11/04/2004 | US20040220100 transdermal drug delivery; nucleic acids |
| 11/04/2004 | US20040219224 Spherical protein particles and methods for making and using them |
| 11/04/2004 | US20040219186 time release agents comprising gel formed from polysaccharides, excipients and drugs |
| 11/04/2004 | US20040219152 Methods for modulating angiogenesis with apelin compositions |
| 11/04/2004 | US20040219146 Prevention and treatment of amyloidogenic disease |
| 11/04/2004 | US20040219105 Human hookworm model and method for maintaining human hookworm in a non-human primate |
| 11/04/2004 | CA2523452A1 Cancer specific monoclonal antibodies |
| 11/04/2004 | CA2522819A1 Polyvalent protein complex |
| 11/04/2004 | CA2522700A1 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 11/03/2004 | EP1471887A2 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 11/03/2004 | EP1471822A1 DYE−BIOCONJUGATES FOR SIMULTANEOUS OPTICAL DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 11/03/2004 | EP1409277B1 Nonskid device for the wheels of vehicles |
| 11/03/2004 | EP1212103B1 4-fluoroalkyl-3-halophenyl nortropanes |
| 11/03/2004 | EP0711179B1 Stabilized microbubble compositions for ultrasound |
| 11/03/2004 | CN2652385Y Package capsule for barium meal fluoroscopy gas producing powder |
| 11/03/2004 | CN1543350A Imunogenic conjugate of carbohydrate haptens and aggregated protein carrier |
| 11/03/2004 | CN1543337A Expandable gastric retention device |
| 11/02/2004 | US6811969 Retentate chromatography—profiling with biospecific interaction adsorbents |
| 11/02/2004 | US6811766 Ultrasound imaging with contrast agent targeted to microvasculature and a vasodilator drug |
| 10/28/2004 | WO2004092404A2 Inhibitors of acidic mammalian chitinase as asthma therapeutics |
| 10/28/2004 | WO2004092325A2 Screening methods using zebrafish to identify thrombotic and anti-thrombotic compounds and genes |
| 10/28/2004 | WO2004091669A1 Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes |
| 10/28/2004 | WO2004091592A2 Methods and compositions to treat myocardial conditions |
| 10/28/2004 | WO2004091581A1 Radioactively marked microparticles, method for the production thereof and use of the same |
| 10/28/2004 | WO2004091397A2 Method of determining state variables and changes in state variables |
| 10/28/2004 | WO2004091396A2 Method for the spatially resolved determination of physical, chemical and/or biological properties or state variables |
| 10/28/2004 | WO2004091395A2 Method for spatially resolved determination of magnetic particle distribution in an area of examination |
| 10/28/2004 | WO2004091394A2 Method to determine the spatial distribution of magnetic particles and magnetic particle administering compositions |
| 10/28/2004 | WO2004091386A2 Arrangement and method for the spatially resolved determination of state variables in an examination area |
| 10/28/2004 | WO2004091382A2 Monitoring circadian activity |
| 10/28/2004 | WO2004091375A2 Epha2 and non-neoplastic hyperproliferative cell disorders |
| 10/28/2004 | WO2004016148A3 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors |
| 10/28/2004 | US20040216176 Compositions and methods for characterizing and regulating Wnt pathways |
| 10/28/2004 | US20040214810 octa(1,4,7,10-tetraoxaundecyl)Gadolinium-phthalocyanine for example; or manganese(II or III) complexes thereof; complex bound to a peptide or polysaccharide; enhancing tissue-specific contrast of magnetic resonance imaging |
| 10/28/2004 | US20040214286 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 10/28/2004 | US20040213833 certain MMP inhibitory peptides improve the targeting of liposomes to cancer cells and enhance the uptake thereof by such cells |
| 10/28/2004 | US20040213829 Cleansing the body of heavy metals with a primary chelator to move a heavy metal species from the central nervous system into the vascular system; and a secondary chelator to capsure and move the metal into an excretion pathway. |
| 10/28/2004 | US20040213756 Methods and compositions to treat myocardial conditions |
| 10/28/2004 | US20040213742 Monitoring marker |
| 10/28/2004 | US20040213741 Dna sequences; gene expression; therapy for trauma injuries |
| 10/28/2004 | US20040213740 Useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo |
| 10/28/2004 | US20040213738 CIRL3-Like proteins, nucleic acids, and methods of modulating CIRL3-L-mediated activity |
| 10/28/2004 | US20040213736 Introducing into the subject a ligand capable of labelling aggregated paired helical filament (PHF) tau protein, determining the presence and\or amount of ligand bound to extracellular aggregated PHF tau in the medial temporal lobe of the brain, correlating the result of the determination |
| 10/28/2004 | US20040211191 Polarized gas accumulators and heating jackets and associated gas collection and thaw methods and polarized gas products |
| 10/28/2004 | DE19827417B4 Material zur unterschiedlichen Modifizierung der optischen Eigenschaften unterschiedlicher Zellen Material for different modification of the optical properties of different cells |
| 10/28/2004 | DE10317461A1 Preparing microparticles labeled with technetium, useful as powders for inhalation, e.g. to study deposition of pharmaceuticals, such as anticholinergic agents, involves incubation with solution of technetium salt |
| 10/28/2004 | CA2521594A1 Epha2 and non-neoplastic hyperproliferative cell disorders |
| 10/27/2004 | EP1470246A2 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 10/27/2004 | EP1470218A2 Corona-virus-like particles comprising functionally deleted genomes |
| 10/27/2004 | EP1470127A1 N, n'-dimethylated n-confused porphyrins |
| 10/27/2004 | EP1469890A1 Responsive paramagnetic mri contrast agents |
| 10/27/2004 | EP1469733A2 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
| 10/27/2004 | EP1244457B1 Use of modulators of annexin for the manufacture of a medicament for the treatment and/or prevention of arthritis and arthritic diseases |
| 10/27/2004 | EP1237578A4 Micro-cluster liquids and methods of making and using them |
| 10/27/2004 | EP1152696B1 Device and method for safe location and marking of a cavity and sentinel lymph nodes |
| 10/27/2004 | EP1012603B1 Functional fragments of hiv-1 vpr protein and methods of using the same |
| 10/27/2004 | EP1000367B1 Contrast agent-enhanced magnetic resonance imaging of tissue perfusion |
| 10/27/2004 | CN1541115A Smulaneous imaging of cardiac perfusion and vitronection receptor targeted imaging agent |
| 10/27/2004 | CN1541114A Conjugates of macrocyclic metal complexes with biomolucules and utilization thereof for producing agents for use in NMR diagnosis and radiodiagnosis and radiotherapy |
| 10/27/2004 | CN1539843A **Tc marked dopamine transport protein developer |
| 10/27/2004 | CN1539506A Combination of developer of B type ultrasonic and preparation method |
| 10/27/2004 | CN1172720C B-type supersonic resetting image intensifying agent for entembole and preparation technology thereof |
| 10/26/2004 | US6809082 Synthetic transfection vectors |
| 10/26/2004 | US6808884 Intercalation compound for use in the diagnosis and detection of genetic disorders |
| 10/26/2004 | US6808720 Charged lipids and uses for the same |
| 10/26/2004 | US6808704 Removing nuclear dna from recipient oocyte to form nuclear transfer agent; activating and culturing to generate non-human embryo; injecting into donor mammal; examining site for teratoma and signs of rejection |
| 10/26/2004 | US6808699 Methods for imaging pulmonary and cardiac vasculature and evaluating blood flow using dissolved polarized 129Xe |
| 10/26/2004 | US6807810 Hyperpolarized gas containers, solenoids, transport and storage devices and associated transport and storage methods |
| 10/26/2004 | CA2177616C Preparation and use of immunoconjugates |
| 10/21/2004 | WO2004090109A2 Ccn3 compositions and methods |
| 10/21/2004 | WO2004089984A1 Antigen recognizing antibody |
| 10/21/2004 | WO2004089424A1 Adducts between magnetic resonance shift reagents and substrates containing exchangeable protons for “cest” applications |
| 10/21/2004 | WO2004089283A2 Compositions and methods for treating viral infections |
| 10/21/2004 | WO2004089190A2 Methods and probes for identifying vulnerable plaque |
| 10/21/2004 | WO2004089072A2 Non-human mammals and animal cells containing a mutated alpha2/delta1 gene |
| 10/21/2004 | WO2004089071A1 Non-human mammals and animal cells containing a mutated alpha2/delta gene |